Interventions for basal cell carcinoma of the skin

Updated review (52 RCTs, n=6,690) reports non‐surgical treatments for low‐risk basal cell carcinoma are less effective than surgical treatments; but recurrence rates are acceptable, cosmetic outcomes are likely superior & imiquimod has the best evidence to support its efficacy.

Cochrane Database of Systematic Reviews